ONE STOP DISPENSING: MEDICATION-ECONOMIC PERSPECTIVES ON SELF-ADMINISTRATING ELECTIVE GASTRIC SURGERY PATIENTS
CP-141
ERIBULIN USE IN METASTATIC BREAST CANCER
CP-140
ANALYSIS OF EFFECTIVENESS, SAFETY AND ADHERENCE IN PATIENTS SWITCHING TO EMTRICITABINE/RILPIVIRINE/TENOFOVIR
CP-137
INVASIVE FUNGAL INFECTIONS: OBSERVATIONAL STUDY IN TWO HOSPITALS IN ITALY (TURIN) AND FRANCE (PARIS)
CP-135
MONITORING AND RATIONALISATION OF ANTIBIOTICS PRESCRIBED IN HOSPITALS
CP-134
ANALYSYS OF THERAPEUTIC RESPONSE AND TOLERABILITY IN PATIENTS TREATED WITH CRIZOTINIB IN ALK POSITIVE NSCLC
CP-133
A PHARMACOECONOMIC EVALUATION IN THE THERAPY EVOLUTION SETTING OF RENAL CELL CARCINOMA
CP-132
IMPACT OF PHARMACEUTICAL INTERVENTIONS IN A MEDICINE DEPARTMENT
CP-128
EXPERIENCE OF USE IN HOSPITAL WITH SOFOSBUVIR: EFFICACY AND SAFETY OF TREATMENT
CP-127
INNAPPROPRIATE PRESCRIBING IN ELDERLY PATIENTS ATTENDING THE EMERGENCY ROOM
CP-125
THE EFFECT OF A PHARMACIST LED INHALER TECHNIQUE ASSESSMENT, EDUCATION AND TRAINING INTERVENTION ON ASTHMA CONTROL TEST SCORES IN A PAEDIATRIC HOSPITAL OUTPATIENT SETTING
CP-122
FIRST CYCLE NEUTROPENIA AND RELATIVE DOSE INTENSITY IN LOCALISED BREAST CANCER PATIENTS TREATED WITH AN ADJUVANT AC PROTOCOL FOLLOWED BY WEEKLY PACLITAXEL
CP-120
DETAILED DOCUMENTATION IN CLINICAL PHARMACY – TOO MUCH EFFORT?
CP-117
RISKS OF SURGICAL INTERVENTION IN PATIENTS TAKING ORAL ANTICOAGULANTS
CP-116
DRUG USE EVALUATION OF HEPARINS PRESCRIBED AS A ‘SINGLE DOSE’ IN HOSPITAL
